DETROIT--(BUSINESS WIRE)--Asterand plc (LSE:ATD), a leading provider of human tissue and services to scientists engaged in drug discovery research, announces that it has entered into a collaborative agreement with Abcam plc (AIM:ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue. Asterand will undertake the validation and characterisation of a selected group of Abcam antibodies for immuno-histochemistry applications using Asterand’s PhaseZERO® Human Tissue Services platform.
